Exhibit 99.1

Prestige Brands Holdings, Inc. Reports Second Quarter & Six Months Fiscal 2008 Results

Irvington, NY, November 8, 2007—Prestige Brands Holdings, Inc. (NYSE-PBH) today announced results for the second quarter and first half of fiscal year 2008, which ended on September 30, 2007.

Net revenues for the second fiscal quarter ended September 30, 2007 were $87.3 million, 3% higher than net revenues of $84.6 million in the prior year comparable period.  Net revenues for the quarter would have been 4% higher, and organic sales for the quarter would have been 2% higher than the prior year quarter were it not for the industry-wide voluntary withdrawal of infant cough/cold products in which the Company participated that affected two Little Remedies® products.  During the quarter, the Company increased its allowance for estimated returns by $1.1 million and its allowance for obsolescence by $0.8 million to reflect the two withdrawn items.

Operating income of $20.6 million was 15% lower than the prior year quarter operating income of $24.1 million.  The reduction in operating income is primarily due to the impact of the Little Remedies withdrawal, as well as increased legal expenditures related to arbitration with OraSure Technologies, Inc., a supplier of Compound W Freeze Off®, and four separate legal actions initiated by the Company involving infringements of its intellectual property relative to its The Doctor’s® Night Guard™ products.

Net income for the second fiscal quarter of $6.8 million, or $0.14 per share, was below last fiscal year’s second quarter net income of $8.8 million, or $0.18 per share.  Excluding the effects of the voluntary Little Remedies withdrawal, net income would have been $8.1 million, or $0.16 per share.

First Six Months of Fiscal 2008

Net revenues for the first six months of fiscal 2008 were $165.9 million, an increase of 3% over the prior year comparable period results of $160.5 million.  Operating income of $43.7 million was 8% below the comparable period’s results of $47.5 million.  Net income of $15.1 million, or $0.30 per share, was 11% below the comparable period’s net income of $17.0 million, or $0.34 per share.

Q2 and Six Month Results by Segment

Over-the-Counter (OTC) Healthcare Products

Net revenues of OTC healthcare products increased 8% to $50.0 million over the comparable period’s results of $46.3 million. Excluding the impact of the acquisition of Wartner® wart remover products in the second quarter of fiscal 2007 and the effects of the increased allowance for returns for the two Little Remedies® products, OTC organic sales increased by 5%.  Increases in the segment were led by the successful introduction of new Murine™ Earigate™ and Clear Eyes® eye care products.

For the six month period ended September 30, 2007, OTC net revenues were $92.4 million compared to $85.9 million in the prior year comparable period, an increase of 8%.

Household Products

Net revenues for the household products segment were $31.4 million, even with the prior year comparable quarter.  An increase in the Chore Boy® line of household scrubbers offset a decline in sales of Spic and Span® household cleaners.  Revenues for Comet®, the segment’s largest brand, were even with the prior year comparable period.  The sales increase generated from the successful introduction of Comet® SprayGel Mildew Stain Remover was offset by inventory reductions at one of our key mass merchandisers.

For the six month period ended September 30, 2007, net revenues for the household products segment were $61.3 million, even with the prior year comparable period.

Personal Care Products

Net revenues for the personal care products segment were $5.9 million, 16% lower than the prior year comparable period results of $7.0 million.  Cutex® nail polish remover and Denorex® shampoo experienced sales decreases versus the prior year period in line with expectations.  Revenues of Prell® shampoo were up slightly for the quarter.

For the first six months of fiscal 2008, net revenues were $12.2 million compared to $13.3 million in the prior year comparable period.

Free Cash Flow and Debt Repayment

Free cash flow is a “non-GAAP” financial measure as that term is defined by the Securities and Exchange Commission in Regulation G.  Free cash flow is presented in this news release because management believes that it is a commonly used measure of liquidity, and indicative of cash available for debt repayment and acquisitions.  The Company defines “free cash flow” as operating cash flow less capital expenditures.

The Company’s free cash flow for the quarter ended September 30, 2007 was $13.0 million, composed of operating cash flow of $13.1 million less capital expenditures of $0.1 million.  This compares to free cash flow of $21.3 million generated in the prior year quarter.  The decline in free cash flow was driven by the year on year reduction in net income combined with an increase in working capital versus the prior year comparable period.

Our continued strong absolute cash flow resulted in a debt pay down of $10.4 million on our term loan during the second fiscal quarter.  Total debt has been reduced to $437.1 million at September 30, 2007.

Commentary

“Our second quarter saw continued progress on the path to sustainable organic growth,” said Mark Pettie, Chairman and CEO.  “Were it not for the industry-wide voluntary withdrawal affecting two of our Little Remedies® products, our organic sales would have been 2% above the year ago comparable period, aided by new product innovation in both our OTC and household businesses.  In addition, efforts toward cost of goods savings are beginning to take effect and have already helped to shelter us from raw material increases,” he said.

Conference Call

The Company will host a conference call to review its second quarter and six month results on Thursday, November 8, 2007 at 8:30 am (ET). The toll free number is 1-800-299-7635 within North America and 1-617-786-2901 outside North America. The conference pass code is “prestige”. Telephonic replays will be available for two weeks following the completion of the call and can be accessed at 1-888-286-8010 within North America, and at 1-617-801-6888 outside of North America. The pass code is 72463596.

About Prestige Brands Holdings, Inc.

Prestige Brands markets and distributes brand name over-the-counter healthcare, personal care and household products sold throughout the United States, Canada and certain international markets. Key brands include Compound W(R) wart treatment, Chloraseptic(R) sore throat relief products, New Skin(R) liquid bandage, Clear Eyes(R) and Murine(R) eye care products, Little Remedies(R) pediatric over-the-counter healthcare products, The Doctor's(R)NightGuard(TM), Cutex(R) nail polish remover, Comet(R) and Spic and Span(R) household cleaners, and other well-recognized brands.

Forward Looking Statements

Note: This news release contains "forward-looking statements" within the meaning of the federal securities laws and is intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the outlook for Prestige Brands Holdings' market and the demand for its products, earnings per share, future cash flows from operations, future revenues and margin requirement and expansion, the success of new product introductions, growth in costs and expenses, and the impact of acquisitions, divestitures, restructurings and other unusual items, including Prestige Brands Holdings' ability to integrate and obtain the anticipated results and synergies from its acquisitions. These projections and statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those projected as a result of certain factors. A discussion of factors that could cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic and other reports filed with the Securities and Exchange Commission.

Contact: Dean Siegal

914-524-6819

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended September 30						Six Months Ended September 30
(In thousands, except per share data)	2007			2006			2007			2006
Revenues
Net sales	$	86,840		$	84,033		$	164,881		$	159,600
Other revenues		497			518			1,067			874
Total revenues		87,337			84,551			165,948			160,474
Cost of Sales
Costs of sales		42,770			41,259			80,092			77,584
Gross profit		44,567			43,292			85,856			82,890
Operating Expenses
Advertising and promotion		11,017			9,455			18,803			16,857
General and administrative		10,184			7,259			17,830			13,693
Depreciation		129			219			253			439
Amortization of intangible assets		2,627			2,193			5,254			4,386
Total operating expenses		23,957			19,126			42,140			35,375
Operating income		20,610			24,166			43,716			47,515
Other income (expense)
Interest income		173			403			360			588
Interest expense		(9,768	)		(10,146	)		(19,642	)		(20,123	)
Total other income (expense)		(9,595	)		(9,743	)		(19,282	)		(19,535	)
Income before provision for income taxes		11,015			14,423			24,434			27,980
Provision for income taxes		4,186			5,639			9,285			10,940
Net income	$	6,829		$	8,784		$	15,149		$	17,040
Basic earnings per share	$	0.14		$	0.18		$	0.30		$	0.35
Diluted earnings per share	$	0.14		$	0.18		$	0.30		$	0.34
Weighted average shares outstanding: Basic		49,710			49,451			49,686			49,389
Diluted		50,046			49,994			50,042			49,991

Prestige Brands Holdings, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands)

Assets	September 30, 2007			March 31, 2007
Current assets
Cash and cash equivalents	$	8,799		$	13,758
Accounts receivable		46,512			35,167
Inventories		27,783			30,173
Deferred income tax assets		3,337			2,735
Prepaid expenses and other current assets		3,628			1,935
Total current assets		90,059			83,768
Property and equipment		1,391			1,449
Goodwill		308,915			310,947
Intangible assets		651,903			657,157
Other long-term assets		8,310			10,095
Total Assets	$	1,060,578		$	1,063,416
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	21,318		$	19,303
Accrued interest payable		7,556			7,552
Other accrued liabilities		12,771			10,505
Current portion of long-term debt		3,550			3,550
Total current liabilities		45,195			40,910
Long-term debt		433,563			459,800
Other long-term liabilities		2,801			2,801
Deferred income tax liabilities		117,609			114,571
Total Liabilities		599,168			618,082
Stockholders’ Equity
Preferred stock - $0.01 par value
Authorized – 5,000 shares
Issued and outstanding – None		--			--
Common stock - $0.01 par value
Authorized – 250,000 shares
Issued – 50,060 shares		501			501
Additional paid-in capital		380,371			379,225
Treasury stock, at cost – 57 shares at September 30, 2007 and 55 shares at March 31, 2007		(44	)		(40	)
Accumulated other comprehensive income		98			313
Retained earnings		80,484			65,335
Total stockholders’ equity		461,410			445,334
Total Liabilities and Stockholders’ Equity	$	1,060,578		$	1,063,416

Prestige Brands Holdings, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended September 30
(In thousands)	2007			2006
Operating Activities
Net income	$	15,149		$	17,040
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		5,507			4,825
Deferred income taxes		4,622			6,197
Amortization of deferred financing costs		1,561			1,609
Stock-based compensation		1,146			224
Changes in operating assets and liabilities
Accounts receivable		(11,345	)		2,595
Inventories		2,390			5,202
Prepaid expenses and other current assets		(1,692	)		(1,047	)
Accounts payable		1,884			4,494
Income taxes payable		--			(1,731	)
Accrued liabilities		2,270			3,326
Net cash provided by operating activities		21,492			42,734
Investing Activities
Purchases of equipment		(194	)		(313	)
Purchase of business		(16	)		(31,242	)
Net cash used for investing activities		(210	)		(31,555	)
Financing Activities
Repayment of long-term debt		(26,237	)		(8,865	)
Purchase of common stock for treasury		(4	)		(6	)
Net cash used for financing activities		(26,241	)		(8,871	)
Increase (decrease) in cash		(4,959	)		2,308
Cash - beginning of period		13,758			8,200
Cash - end of period	$	8,799		$	10,508
Interest paid	$	18,078		$	18,306
Income taxes paid	$	5,664		$	6,287

Prestige Brands Holdings, Inc.

Consolidated Segment Operations

(Unaudited)

	Three Months Ended September 30, 2007
	Over-the-Counter		Household		Personal
	Healthcare		Cleaning		Care		Consolidated
Net sales	$	50,003		30,925	$	5,912	$	86,840
Other revenues		--		497		--		497
Total revenues		50,003		31,422		5,912		87,337
Cost of sales		19,688		19,587		3,495		42,770
Gross profit		30,315		11,835		2,417		44,567
Advertising and promotion		8,154		2,575		288		11,017
Contribution margin	$	22,161	$	9,260	$	2,129		33,550
Other operating expenses								12,940
Operating income								20,610
Other (income) expense								9,595
Provision for income taxes								4,186
Net income							$	6,829

	Six Months Ended September 30, 2007
	Over-the-Counter		Household		Personal
	Healthcare		Cleaning		Care		Consolidated
Net sales	$	92,429	$	60,270	$	12,182	$	164,881
Other revenues		--		1,039		28		1,067
Total revenues		92,429		61,309		12,210		165,948
Cost of sales		35,074		37,980		7,038		80,092
Gross profit		57,355		23,329		5,172		85,856
Advertising and promotion		14,035		4,203		565		18,803
Contribution margin	$	43,320	$	19,126	$	4,607		67,053
Other operating expenses								23,337
Operating income								43,716
Other (income) expense								19,282
Provision for income taxes								9,285
Net income							$	15,149

Prestige Brands Holdings, Inc.

Consolidated Segment Operations

(Unaudited)

	Three Months Ended September 30, 2006
	Over-the-Counter Healthcare		Household Cleaning		Personal Care		Consolidated
Net sales	$	46,255	$	30,732	$	7,046	$	84,033
Other revenues		--		518		--		518
Total revenues		46,255		31,250		7,046		84,551
Cost of sales		18,001		18,941		4,317		41,259
Gross profit		28,254		12,309		2,729		43,292
Advertising and promotion		7,058		2,020		377		9,455
Contribution margin	$	21,196	$	10,289	$	2,352		33,837
Other operating expenses								9,671
Operating income								24,166
Other (income) expense								9,743
Provision for income taxes								5,639
Net income							$	8,784

	Six Months Ended September 30, 2006
	Over-the-Counter Healthcare		Household Cleaning		Personal Care		Consolidated
Net sales	$	85,853	$	60,470	$	13,277	$	159,600
Other revenues		--		874		--		874
Total revenues		85,853		61,344		13,277		160,474
Cost of sales		32,398		37,095		8,091		77,584
Gross profit		53,455		24,249		5,186		82,890
Advertising and promotion		12,483		3,710		664		16,857
Contribution margin	$	40,972	$	20,539	$	4,522		66,033
Other operating expenses								18,518
Operating income								47,515
Other (income) expense								19,535
Provision for income taxes								10,940
Net income							$	17,040